Clinical trials: Structural Heart Abnormality
Mitral Valve Disease, Heart Valve Diseases
Autonomous Robotics for Transcatheter Cardiac Procedures
Cardiovascular diseases represent the most common cause of death worldwide. Percutaneous approaches with intravascular catheters are pivotal, since they allow to treat patients with high perioperative risks.
- Conditions
- Mitral Valve Disease, Heart Valve Diseases, Structural Heart Abnormality
- Trial name
- ARTERY (NCT04787757)
- Testing
- Percutaneous cardiac procedure
- Where
- Italy
- Volunteers
- 401 people
- Sponsor
- Università Vita-Salute San Raffaele
Radiotherapy; Complications, Ventricular Tachycardia
Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia
Ventricular tachycardia (VT) is an abnormal rhythm arising from the bottom chambers (ventricles) of the heart. The hearts of most patients who develop VT have been previously damaged by a myocardial infarction (heart attack) or…
- Conditions
- Radiotherapy; Complications, Ventricular Tachycardia, Structural Heart Abnormality, Heart Failure
- Trial name
- SABRE-VT (NCT05696522)
- Testing
- Stereotactic ablative radiotherapy
- Where
- United Kingdom
- Volunteers
- 4 people
- Sponsor
- Barts & The London NHS Trust
Structural Heart Abnormality
Prince of Wales Hospital Structural Heart Registry
Structural heart disease refers to a group of cardiac defects other than coronary artery disease. Structural heart intervention is a rapidly growing field in cardiology.
- Trial name
- NCT07020286
- Testing
- Structural heart interventions
- Where
- Hong Kong
- Volunteers
- 1,000 people
- Sponsor
- Prince of Wales Hospital, Shatin, Hong Kong
Structural Heart Abnormality, Structural Heart Disease
Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Interpretation
HEART-AI is a pragmatic randomized trial currently active at Montreal Heart Institute, with planned multicenter expansion testing whether an artificial intelligence (AI) score from a routine 12-lead electrocardiogram (ECG) helps…
- Trial name
- HEART-AI (NCT06462989)
- Testing
- ECHONEXT
- Where
- Canada
- Volunteers
- 5,700 people
- Sponsor
- Montreal Heart Institute
Percutaneous Coronary Intervention, Heart Failure
REgiStry-based Cardiovascular qUality improvEment Research
The goal of this registry-based observational study is to establish a comprehensive management plan, which focus on medical therapy, cardiac rehabilitation and active post-market surveillance of medical devices, in patients with…
- Conditions
- Percutaneous Coronary Intervention, Heart Failure, Cardiometabolic Syndrome, Structural Heart Abnormality
- Trial name
- RESCUER (NCT06137885)
- Testing
- Cardiac rehabilitation, Active post-market surveillance of devices, Multi-omics approach to precision medicine
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- Peking University Third Hospital
Structural Heart Abnormality, Valve Heart Disease
Capitalizing on AI to CapTure Undiagnosed Structural Heart Disease
Doctors are testing a new tool called EchoNext to see if it can help find heart problems earlier. EchoNext looks at the heart's electrical test, called an ECG, and uses artificial intelligence (AI) to check for signs of…
- Conditions
- Structural Heart Abnormality, Valve Heart Disease, Heart Diseases, Cardiovascular Diseases
- Trial name
- CACTUS (NCT07843004)
- Testing
- EHR Alert
- Where
- United States
- Volunteers
- 4,000 people
- Sponsor
- Pierre Elias
Structural Heart Abnormality
The SALMANTICOR Study
The SALMANTICOR study will obtain data on the prevalence and incidence of structural heart disease in a population setting. A cross-section survey of randomly selected residents of Salamanca (Spain) will be performed.
- Trial name
- SALMANTICOR (NCT03429452)
- Where
- Spain
- Volunteers
- 2,057 people
- Sponsor
- AORTICA Group
Structural Heart Abnormality
Diagnosis of Structural Heart Disease Using MCG
The purpose of this prospective cohort study is to determine the parameters of cardiac magnetic imaging to identify structural heart disease using use transthoracic echocardiography or cardiac magnetic resonance as reference…
- Trial name
- NCT06315998
- Testing
- Magnetocardiography
- Where
- China
- Volunteers
- 2,914 people
- Sponsor
- Qilu Hospital of Shandong University
Transthoracic Echocardiography, Suspected or Known Structural or Functional Cardiac Abnormality
Study to Determine Safety and Dosage of OPTISON in Pediatric Participants
Study to determine the safety and appropriate dosage of OPTISON in pediatric participants since OPTISON has been tested in adult participants only during the clinical development
- Trial name
- NCT03740997
- Testing
- Optison
- Where
- 8 sites in United States
- Volunteers
- 39 people
- Sponsor
- GE Healthcare